Literature DB >> 109545

Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

E J Ziegler, H Douglas.   

Abstract

During attempts to create a realistic model of fatal bacteremia due to Pseudomonas aeruginosa during immunosuppression, it was found that the invasive as well as the disseminated phase of infection could be mimicked by gentle instillation of 10(8) colony-forming units of P. aeruginosa into the intact conjunctival sac of agranulocytic rabbits. Within 48 hr animals developed conjunctivits leading to severe necrotizing vasculitis and fatal bacteremia. Twelve of 26 strains from patients with P. aeruginosa infections were virulent, causing death in 50%--100% of animals. Nine (75%) of 12 isolates from blood but only two (15%) of 13 isolates from sputum and urine were highly lethal. Neither proteolytic enzyme production nor serum resistance alone accounted for virulence. No infection developed in animals and normal leukocyte counts or in neutropenic animals given Escherichia coli, Klebsiella pneumoniae, or non-aeruginosa pseudomonads. A rare vasculitic lesion was observed in animals inoculated with Serratia marcescens. This model, which illustrates the distinctive features of P. aeruginosa infection, is so simple and reproducible that it should be useful for evaluation of the efficacy of drugs and immunization against Pseudomonas in the compromised host.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109545     DOI: 10.1093/infdis/139.3.288

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.

Authors:  Bryan J Berube; Katherine R Murphy; Matthew C Torhan; Nicholas O Bowlin; John D Williams; Terry L Bowlin; Donald T Moir; Alan R Hauser
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

Authors:  M C Cerquetti; D O Sordelli; J A Bellanti; A M Hooke
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.

Authors:  L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Production of alkaline protease by Pseudomonas aeruginosa.

Authors:  S J Cryz; B H Iglewski
Journal:  J Clin Microbiol       Date:  1980-07       Impact factor: 5.948

5.  Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells.

Authors:  M C Plotkowski; A M Saliba; S H Pereira; M P Cervante; O Bajolet-Laudinat
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

7.  Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia.

Authors:  Y Hirakata; K Tomono; K Tateda; T Matsumoto; N Furuya; K Shimoguchi; M Kaku; K Yamaguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Cloning of a phosphate-regulated hemolysin gene (phospholipase C) from Pseudomonas aeruginosa.

Authors:  M L Vasil; R M Berka; G L Gray; H Nakai
Journal:  J Bacteriol       Date:  1982-10       Impact factor: 3.490

9.  Serum-induced lysis of Pseudomonas aeruginosa.

Authors:  T Meshulam; H Verbrugh; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

10.  Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.